Risk of hepatitis B virus reactivation in hepatitis B virus + hepatitis C virus‐co‐infected patients with compensated liver cirrhosis treated with ombitasvir, paritaprevir/r + dasabuvir + ribavirin.

Saved in:
Bibliographic Details
Title: Risk of hepatitis B virus reactivation in hepatitis B virus + hepatitis C virus‐co‐infected patients with compensated liver cirrhosis treated with ombitasvir, paritaprevir/r + dasabuvir + ribavirin.
Authors: Preda, C. M.1 carmenmonica.preda@gmail.com, Popescu, C. P.2, Baicus, C.3, Constantinescu, I.1, Oproiu, A.1, Voiosu, T.3, Diculescu, M.1, Negreanu, L.4, Gheorghe, L.1, Sporea, I.5, Trifan, A.6, Ceausu, E.2, Proca, D.1, Manuc, M.1
Source: Journal of Viral Hepatitis. Jul2018, Vol. 25 Issue 7, p834-841. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:13520504
DOI:10.1111/jvh.12872